Your browser doesn't support javascript.
loading
A Physiologically Based Pharmacokinetic Model for Naphthalene With Inhalation and Skin Routes of Exposure.
Kapraun, Dustin F; Schlosser, Paul M; Nylander-French, Leena A; Kim, David; Yost, Erin E; Druwe, Ingrid L.
Afiliação
  • Kapraun DF; Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Durham, North Carolina 27711.
  • Schlosser PM; Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Durham, North Carolina 27711.
  • Nylander-French LA; Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
  • Kim D; Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
  • Yost EE; Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Durham, North Carolina 27711.
  • Druwe IL; Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Durham, North Carolina 27711.
Toxicol Sci ; 177(2): 377-391, 2020 10 01.
Article em En | MEDLINE | ID: mdl-32687177
ABSTRACT
Naphthalene, a volatile organic compound present in moth repellants and petroleum-based fuels, has been shown to induce toxicity in mice and rats during chronic inhalation exposures. Although simpler default methods exist for extrapolating toxicity points of departure from animals to humans, using a physiologically based pharmacokinetic (PBPK) model to perform such extrapolations is generally preferred. Confidence in PBPK models increases when they have been validated using both animal and human in vivo pharmacokinetic (PK) data. A published inhalation PBPK model for naphthalene was previously shown to predict rodent PK data well, so we sought to evaluate this model using human PK data. The most reliable human data available come from a controlled skin exposure study, but the inhalation PBPK model does not include a skin exposure route; therefore, we extended the model by incorporating compartments representing the stratum corneum and the viable epidermis and parameters that determine absorption and rate of transport through the skin. The human data revealed measurable blood concentrations of naphthalene present in the subjects prior to skin exposure, so we also introduced a continuous dose-rate parameter to account for these baseline blood concentration levels. We calibrated the three new parameters in the modified PBPK model using data from the controlled skin exposure study but did not modify values for any other parameters. Model predictions then fell within a factor of 2 of most (96%) of the human PK observations, demonstrating that this model can accurately predict internal doses of naphthalene and is thus a viable tool for use in human health risk assessment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exposição por Inalação / Modelos Biológicos / Naftalenos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exposição por Inalação / Modelos Biológicos / Naftalenos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article